Acute megakaryoblastic leukemia laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Acute megakaryoblastic leukemia}} | {{Acute megakaryoblastic leukemia}} | ||
{{CMG}}; {{AE}} | |||
==Overview== | |||
==Laboratory Findings== | |||
The diagnosis of AMKL (M7) is based on the following: | The diagnosis of AMKL (M7) is based on the following: | ||
#Bone marrow biopsy demonstrating 30% or more leukemic cells | #[[Bone marrow]] [[biopsy]] demonstrating 30% or more leukemic cells of megakaryocytic lineage | ||
#Conducting tests that detect platelet-specific antibodies which could be monoclonal or polyclonal. | #Conducting tests that detect [[platelet-specific antibodies]] which could be [[monoclonal]] or [[polyclonal]]. | ||
#Bone marrow biopsy is recommended in patients who developed [[myelofibrosis]]. Visualization of blasts and mature megakaryocytes on biopsy sections is diagnostic. | |||
==References== | ==References== | ||
Latest revision as of 14:23, 26 April 2021
|
Acute megakaryoblastic leukemia Microchapters |
|
Differentiating Acute megakaryoblastic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acute megakaryoblastic leukemia laboratory findings On the Web |
|
American Roentgen Ray Society Images of Acute megakaryoblastic leukemia laboratory findings |
|
Acute megakaryoblastic leukemia laboratory findings in the news |
|
Blogs on Acute megakaryoblastic leukemia laboratory findings |
|
Directions to Hospitals Treating Acute megakaryoblastic leukemia |
|
Risk calculators and risk factors for Acute megakaryoblastic leukemia laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Laboratory Findings
The diagnosis of AMKL (M7) is based on the following:
- Bone marrow biopsy demonstrating 30% or more leukemic cells of megakaryocytic lineage
- Conducting tests that detect platelet-specific antibodies which could be monoclonal or polyclonal.
- Bone marrow biopsy is recommended in patients who developed myelofibrosis. Visualization of blasts and mature megakaryocytes on biopsy sections is diagnostic.